Kristie Sullivan

Nanomaterial Categorization for Assessing Risk Potential To Facilitate Regulatory Decision-Making

Hilary A. Godwin, Catherine Nameth, David Avery et al. · ACS Nano · 2015 · 141 citations

Engineering, Nanomaterials Regulations, Nanotoxicology +25

An Adverse Outcome Pathway for Sensitization of the Respiratory Tract by Low-Molecular-Weight Chemicals: Building Evidence to Support the Utility of <i>In Vitro</i> and <i>In Silico</i> Methods in a Regulatory Context

Kristie Sullivan, Steven J. Enoch, Janine Ezendam et al. · Applied In Vitro Toxicology · 2017 · 72 citations · Full text

Adverse outcome pathways: From research to regulation scientific workshop report

Nicole Kleinstreuer, Kristie Sullivan, David Allen et al. · Regulatory Toxicology and Pharmacology · 2016 · 64 citations · Full text

Health Effect, Health Policy, Health Outcome +8

Building on a solid foundation: SAR and QSAR as a fundamental strategy to reduce animal testing

Kristie Sullivan, Joseph Manuppello, Catherine Willett · SAR and QSAR in environmental research · 2014 · 38 citations

Toxicology Testing, Laboratory Animal Study, Solid Foundation +16

Application of an Integrated Testing Strategy to the U.S. EPA Endocrine Disruptor Screening Program

Catherine Willett, Patricia L. Bishop, Kristie Sullivan · Toxicological Sciences · 2011 · 38 citations · Full text

Integrated Testing, Drug Screening, Pesticide Atrazine +21